Advertisement

Synthesis of Peptidomimics Through Sugar-Based Scaffolds

  • Yves Le Merrer
  • Lydie Poitout
  • Jean-Claude Depezay
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 23)

Abstract

Poor oral bioavailability, low metabolic stability towards proteolysis and rapid excretion via both liver and kidneys displayed by innumerable peptides of potential therapeutic value has generated an intensive search for peptidomimics (1, 2). A possible approach of such nonpeptidal peptidomimics is to replace the peptide by a scaffold that distributes in the space the peptidal side chains of amino acids essential for biological activity and mimics the bioactive conformation of the peptide.

Keywords

Aqueous Layer Anhydrous Na2SO4 Combine Organic Layer Saturated Aqueous Solution Azido Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Holzemann, G. (1991) Peptide conformation mimetics. Kontakte (Darmstadt) 3–12 and 55–63.Google Scholar
  2. 2.
    Giannis, A. and Kolter, T. (1993) Peptidomimetics for receptor ligands-discovery, development, and medical perspectives. Angew. Chem. Int. Ed. Engl. 32, 1244–1267.CrossRefGoogle Scholar
  3. 3.
    Belanger, P. C. and Dufresne, C. (1986) Preparation of exo-6-benzyl-exo-2-(m-hydroxyphenyl)-l-dimethylaminobicyclo[2.2.2]octane. A non-peptide mimic of enkephalins. Can. J. Chem. 64, 1514–1520.CrossRefGoogle Scholar
  4. 4.
    Hirschmann, R., Sprengeler, P. A., Kawasaki, T., Leahy, J. W., Shakespeare, W. C, and Smith, A. B., III (1993) The versatile steroid nucleus: design and synthesis of a peptidomimetic employing this novel scaffold. Tetrahedron 49, 3665–3676.CrossRefGoogle Scholar
  5. 5.
    Hirschmann, R., Nicolaou, K. C, Pietranico, S., Salvino, J., Leahy, E. M., Sprengeler, P. A., Furst, G., Smith, A.B., III, Strader, C. D., Cascieri, M. A., Candelore, M. R., Donaldson, C., Vale, W., and Maechler, L. (1992) Nonpeptidal peptidomimetics with a β-d-glucose scaffolding. A partial Somatostatin agonist bearing a close structural relationship to a potent, selective substance P antagonist. J. Am. Chem. Soc. 114, 9217–9218.CrossRefGoogle Scholar
  6. 6.
    Hirschmann, R., Nicolaou, K. C., Pietranico, S., Leahy, E. M., Salvino, J., Arison, B., Cichy, M. A., Spoors, P. G., Shakespeare, W.C., Sprengeler, P.A., Hamley, P., Smith, A. B., III, Reisine, T., Raynor, K., Maechler, L., Donaldson, C, Vale, W., Freidinger, R. M., Cascieri, M. R., and Strader C. D. (1993) De novo design and synthesis of Somatostatin non-peptide peptidomimetics utilizing β-d-glucose as a novel scaffolding. J. Am. Chem. Soc. 115, 12,550–12,568.CrossRefGoogle Scholar
  7. 7.
    Le Diguarher, T., Boudon, A., Elwell, C, Paterson, D. E., and Billington, D. C. (1996) Synthesis of potential peptidomimetics based on highly substituted glucose and allose scaffolds. Biorg. Med. Chem. Lett. 6, 1983–1988.CrossRefGoogle Scholar
  8. 8.
    Papageorgiou, C, Haltiner, R., Bruns, C, and Petcher, T. J. (1992) Design, synthesis, and binding affinity of a nonpeptide mimic of somatostatin. Bioorg. Med. Chem. Lett. 2, 135–140.CrossRefGoogle Scholar
  9. 9.
    Papageorgiou, C. and Borer, X. (1996) A non-peptide ligand for the somatostatin receptor having a benzodiazepine structure. Bioorg. Med. Chem. Lett. 6, 267–272.CrossRefGoogle Scholar
  10. 10.
    Le Merrer, Y., Poitout, L., Depezay, J.-C, Dosbaa, I., Geoffroy, S., and Foglietti, M.-J. (1997) Synthesis of azasugars as potent inhibitors of glycosidases. Bioorg. Med. Chem. 5, 519–533.CrossRefGoogle Scholar
  11. 11.
    Damour, D., Barreau, M., Blanchard, J.-C, Burgevin, M.-C, Doble, A., Herman, F., Pantel, G., James-Surcouf, E., Vuilhorgne, M., Mignani, S., Poitout, L., Le Merrer, Y., and Depezay, J.-C. (1996) Design, synthesis and binding affinities of novel non-peptide mimics of Somatostatin/Sandostatin®. Bioorg. Med. Chem. Lett. 6, 1667–1672.CrossRefGoogle Scholar
  12. 12.
    Damour, D., Depezay, J.-C, Le Merrer, Y., Mignani, S., Pantel, G., and Poitout, L. (1995) Dérivés de la tryptamine, leur préparation et les médicaments les contenant French Patent application # 95 05510.Google Scholar
  13. 13.
    Lamberts, S. W. J., Krenning, E. P., and Reubi, J.-C. (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev. 12, 450–482.CrossRefGoogle Scholar
  14. 14.
    Hoyer, D., Bell, G. I., Berelowitz, M., Epelbaum, J., Feniuk, W., Humphrey, P. P. A., O’Caroll, A.-M., Patel, Y. C, Schonbrunn, A., Taylor, J. E., and Reisine, T. (1995) Classification and nomenclature of somatostatin receptors. Trends Pharmacol. Sci. 16, 86–88.CrossRefGoogle Scholar
  15. 15.
    Huang, Z., He Yα-Bo, Raynor, K., Tallent, M., Reisine, T., and Goodman, M. (1992) Main chain and side chain chiral methylated somatostatin analogs: synthesis and conformational analyses. J. Am. Chem. Soc. 114, 9390–9400.CrossRefGoogle Scholar
  16. 16.
    Moreau, J. P. and DeFeudis, F. V. (1987) Pharmacological studies of somatostatin and somatostatin-analogs: therapeutic advances and perspectives. Life Sci. 40, 419–437.CrossRefGoogle Scholar
  17. 17.
    Hocart, S. J., Reddy, V., Murphy, W. A. and Coy, D. H. (1995) Three-dimensional quantitative structure-activty relationships of somatostatin analogs. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies. J. Med. Chem. 38, 1974–1989.CrossRefGoogle Scholar
  18. 18.
    Wolf, H. (1947) Reactions and generation of hydrazoic acid. Org. React. 3, 8–45.Google Scholar
  19. 19.
    Hughes, D. L. (1992) The Mitsunobu reaction. Org. React. 42, 335–656.Google Scholar
  20. 20.
    Jurczak, J., Bauer, T., and Chmielewski, M. (1987) A general approach to the synthesis of 2,3-di-O-protected derivatives of d-glyceraldehyde. Carbohydr. Res. 164, 493–498.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 1999

Authors and Affiliations

  • Yves Le Merrer
    • 1
  • Lydie Poitout
    • 1
  • Jean-Claude Depezay
    • 1
  1. 1.Laboratoire de Chimie et de Biochimie Pharmacologiques et ToxicologiquesUniversite Rene DescartesParisFrance

Personalised recommendations